Published in Ann Hum Genet on February 19, 2008
Identification of population substructure among Jews using STR markers and dependence on reference populations included. BMC Genet (2010) 0.91
An ancient autosomal haplotype bearing a rare achromatopsia-causing founder mutation is shared among Arab Muslims and Oriental Jews. Hum Genet (2010) 0.88
Genetic study of the PAH locus in the Iranian population: familial gene mutations and minihaplotypes. Metab Brain Dis (2017) 0.75
RAFTK/Pyk2-mediated cellular signalling. Cell Signal (2000) 2.76
Halting angiogenesis suppresses carcinoma cell invasion. Nat Med (1997) 2.61
Peptidase-deficient mutants of Escherichia coli. J Bacteriol (1978) 2.57
Isodisomy of chromosome 7 in a patient with cystic fibrosis: could uniparental disomy be common in humans? Am J Hum Genet (1989) 2.43
Circadian rhythms of melatonin and cortisol in aging. Biol Psychiatry (1989) 2.41
Mutations of PVRL1, encoding a cell-cell adhesion molecule/herpesvirus receptor, in cleft lip/palate-ectodermal dysplasia. Nat Genet (2000) 2.39
Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules. Br J Cancer (2003) 2.38
Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci U S A (1997) 2.36
The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet (1997) 2.28
The blepharophimosis, ptosis, and epicanthus inversus syndrome: delineation of two types. Am J Hum Genet (1983) 2.15
Infusion of platelets transiently reduces nucleoside overload in MNGIE. Neurology (2006) 1.98
Basal cortisol levels and cognitive deficits in human aging. J Neurosci (1994) 1.97
Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes. Am J Hum Genet (1999) 1.88
Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer. J Clin Oncol (1999) 1.84
The related adhesion focal tyrosine kinase is tyrosine-phosphorylated after beta1-integrin stimulation in B cells and binds to p130cas. J Biol Chem (1997) 1.69
Can we rely on the family history? Am J Med Genet (1998) 1.61
Mucolipidosis type IV: clinical spectrum and natural history. Pediatrics (1987) 1.59
Circular dichroism studies of barnase and its mutants: characterization of the contribution of aromatic side chains. Biochemistry (1993) 1.53
Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy. Allergy (2004) 1.52
Hypertrophy of the tongue associated with inhaled corticosteroid therapy in premature infants. J Pediatr (1995) 1.48
A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group. Neurology (1996) 1.45
CTNS mutations in an American-based population of cystinosis patients. Am J Hum Genet (1998) 1.41
Prescribing discrepancies likely to cause adverse drug events after patient transfer. Qual Saf Health Care (2009) 1.41
Feto-feto-fetal transfusion syndrome in monozygotic monochorionic triamniotic triplets: vascular evaluation by a cast model. Placenta (2005) 1.40
Cleft lip and palate, pili torti, malformed ears, partial syndactyly of fingers and toes, and mental retardation: a new syndrome? J Med Genet (1987) 1.40
Hermansky-Pudlak syndrome and related disorders of organelle formation. Traffic (2000) 1.40
Hyperphosphatasemia in infantile GM1 gangliosidosis: possible association with microscopic bone marrow osteoblastosis. J Pediatr (1990) 1.40
Factors in the development of severe forms of tardive dyskinesia. Am J Psychiatry (1990) 1.39
An outbreak of foodborne streptococcal throat infection. Isr J Med Sci (1994) 1.39
NTBC and alkaptonuria. Am J Hum Genet (1998) 1.38
Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation. Br J Haematol (1994) 1.38
Characterization of RAFTK, a novel focal adhesion kinase, and its integrin-dependent phosphorylation and activation in megakaryocytes. Blood (1996) 1.38
The related adhesion focal tyrosine kinase forms a complex with paxillin in hematopoietic cells. J Biol Chem (1996) 1.37
The genomic region encompassing the nephropathic cystinosis gene (CTNS): complete sequencing of a 200-kb segment and discovery of a novel gene within the common cystinosis-causing deletion. Genome Res (2000) 1.32
A to G polymorphism in ELN gene. Nucleic Acids Res (1991) 1.31
SHP2 mediates the protective effect of interleukin-6 against dexamethasone-induced apoptosis in multiple myeloma cells. J Biol Chem (2000) 1.31
Detection and sorting of neural spikes using wavelet packets. Phys Rev Lett (2000) 1.31
Hermansky-Pudlak syndrome type 3 in Ashkenazi Jews and other non-Puerto Rican patients with hypopigmentation and platelet storage-pool deficiency. Am J Hum Genet (2001) 1.28
Characterization of Mayven, a novel actin-binding protein predominantly expressed in brain. Mol Biol Cell (1999) 1.23
Elevated levels of serum interleukin-1 beta in combat-related posttraumatic stress disorder. Biol Psychiatry (1997) 1.21
RAFTK/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion. Oncogene (2000) 1.20
Activation of p38 mitogen-activated protein kinase by PYK2/related adhesion focal tyrosine kinase-dependent mechanism. J Biol Chem (1999) 1.20
IV. Complications from tattoos. J Dermatol Surg Oncol (1979) 1.18
NRP/B, a novel nuclear matrix protein, associates with p110(RB) and is involved in neuronal differentiation. J Cell Biol (1998) 1.18
Two different connexin 26 mutations in an inbred kindred segregating non-syndromic recessive deafness: implications for genetic studies in isolated populations. Hum Mol Genet (1997) 1.18
The role of denial in recovery from coronary heart disease. Psychosom Med (1987) 1.17
Vascular endothelial growth factor up-regulates ICAM-1 expression via the phosphatidylinositol 3 OH-kinase/AKT/Nitric oxide pathway and modulates migration of brain microvascular endothelial cells. J Biol Chem (2000) 1.15
International epidemiological and microbiological study of outbreak of Salmonella agona infection from a ready to eat savoury snack--II: Israel. BMJ (1996) 1.15
Mutations of CTNS causing intermediate cystinosis. Mol Genet Metab (1999) 1.15
Studies on the synthesis of insulin from natural and synthetic A and B chains. II. Isolation of insulin from recombination mixtures of natural A and B chains. Biochemistry (1967) 1.14
Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil. J Clin Oncol (1996) 1.12
Preseptal and orbital cellulitis in childhood. A changing microbiologic spectrum. Ophthalmology (1998) 1.12
Homozygosity mapping of achromatopsia to chromosome 2 using DNA pooling. Hum Mol Genet (1997) 1.11
Insulin autoantibodies in the pre-diabetic period: correlation with islet cell antibodies and development of diabetes. Diabetologia (1986) 1.11
A single origin of phenylketonuria in Yemenite Jews. Nature (1990) 1.11
Asplenia and polysplenia syndromes with abnormalities of lateralisation in a sibship. J Med Genet (1981) 1.11
The related adhesion focal tyrosine kinase differentially phosphorylates p130Cas and the Cas-like protein, p105HEF1. J Biol Chem (1997) 1.11
Multiple mutations are responsible for the high frequency of metachromatic leukodystrophy in a small geographic area. Am J Hum Genet (1995) 1.10
Molecular cloning and characterization of human VPS18, VPS 11, VPS16, and VPS33. Gene (2001) 1.10
Safety, tolerability, pharmacokinetics and pharmacodynamics of AZD8055 in advanced solid tumours and lymphoma. Br J Cancer (2012) 1.09
The tyrosine kinase PYK-2/RAFTK regulates natural killer (NK) cell cytotoxic response, and is translocated and activated upon specific target cell recognition and killing. J Cell Biol (2000) 1.09
Lipomatous lesions of the parotid gland. Potential pitfalls in fine needle aspiration biopsy diagnosis. Acta Cytol (1991) 1.09
Multiple mutations in a specific gene in a small geographic area: a common phenomenon? Am J Hum Genet (1996) 1.08
Activation of P2Y2 receptors by UTP and ATP stimulates mitogen-activated kinase activity through a pathway that involves related adhesion focal tyrosine kinase and protein kinase C. J Biol Chem (1998) 1.08
Histopathology of the inferior turbinate with compensatory hypertrophy in patients with deviated nasal septum. Laryngoscope (2000) 1.07
Two different mutations are responsible for Krabbe disease in the Druze and Moslem Arab populations in Israel. Hum Genet (1996) 1.07
Governor's blue-ribbon panel on living and dying with dignity. Hawaii Med J (1998) 1.07
Localization of the Krabbe disease gene (GALC) on chromosome 14 by multipoint linkage analysis. Am J Hum Genet (1993) 1.07
Longitudinal study of basal cortisol levels in healthy elderly subjects: evidence for subgroups. Neurobiol Aging (1996) 1.07
Electroencephalograms and autopsy findings in geropsychiatry. J Gerontol (1978) 1.06
Isolation and characterization of a cDNA that encodes the peptide core of the secretory granule proteoglycan of human promyelocytic leukemia HL-60 cells. J Biol Chem (1988) 1.05
Molecular genetics of metachromatic leukodystrophy. Hum Mutat (1994) 1.05
Tyrosine phosphorylation of the related adhesion focal tyrosine kinase in megakaryocytes upon stem cell factor and phorbol myristate acetate stimulation and its association with paxillin. J Biol Chem (1997) 1.05
Prevalence of cystic fibrosis mutations in Israeli Jews. Genet Test (2001) 1.05
RAFTK, a novel member of the focal adhesion kinase family, is phosphorylated and associates with signaling molecules upon activation of mature T lymphocytes. J Exp Med (1997) 1.04
The frequency of the C854 mutation in the aspartoacylase gene in Ashkenazi Jews in Israel. Am J Hum Genet (1994) 1.04
Combined enzymatic and linkage analysis for heterozygote detection in Hunter syndrome: identification of an apparent case of germinal mosaicism. Am J Med Genet (1993) 1.03
Prevalence of tardive dyskinesia in affective disorder patients. J Clin Psychiatry (1983) 1.03
Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interleukin-2. Blood (1998) 1.02
Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells. J Clin Invest (1997) 1.02
Peak bone mass in patients with phenylketonuria. J Inherit Metab Dis (2007) 1.02
Transient neonatal diabetes mellitus in a child with invdup(6)(q22q23) of paternal origin. Eur J Hum Genet (1998) 1.01
Assessing the new federalism: an introduction. Health Aff (Millwood) (1998) 1.01
A common-source outbreak of fulminant hepatitis B in a hospital. Ann Intern Med (1989) 1.01
Direct association of Csk homologous kinase (CHK) with the diphosphorylated site Tyr568/570 of the activated c-KIT in megakaryocytes. J Biol Chem (1997) 1.01
Atelectasis, retraction pockets and cholesteatoma. Acta Otolaryngol (1982) 1.01
Characterization of a human eosinophil proteoglycan, and augmentation of its biosynthesis and size by interleukin 3, interleukin 5, and granulocyte/macrophage colony stimulating factor. J Biol Chem (1988) 1.00
Hunter's syndrome: activity of iduronate sulfate sulfatase in the serum of pregnant heterozygotes. N Engl J Med (1984) 1.00
Beta-chemokine receptor CCR5 signals through SHP1, SHP2, and Syk. J Biol Chem (2000) 0.99
Erlotinib 'dosing-to-rash': a phase II intrapatient dose escalation and pharmacologic study of erlotinib in previously treated advanced non-small cell lung cancer. Br J Cancer (2011) 0.99
Tyrosine phosphorylation of the novel protein-tyrosine kinase RAFTK during an early phase of platelet activation by an integrin glycoprotein IIb-IIIa-independent mechanism. J Biol Chem (1997) 0.99
Krabbe disease: increased incidence in a highly inbred community. Am J Med Genet (1985) 0.99
Histamine-activated, non-selective cation currents and Ca2+ transients in endothelial cells from human umbilical vein. Pflugers Arch (1993) 0.98
Hermansky-Pudlak syndrome and Chediak-Higashi syndrome: disorders of vesicle formation and trafficking. Thromb Haemost (2001) 0.98
Bilateral Mondor's disease. Arch Dermatol (1967) 0.98
Phase I trial of PN401, an oral prodrug of uridine, to prevent toxicity from fluorouracil in patients with advanced cancer. J Clin Oncol (1997) 0.98